MEGAN PLUNKETT: Open Payments
NPI 1609576610 · AIKEN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 36 payments from 12 companies in 2025. Trend: 2023 $642 · 2024 $1,059 · 2025 $816
Food & beverage: $816
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $222 |
| Novo Nordisk Inc | 7 | $146 |
| Corcept Therapeutics | 4 | $86 |
| PFIZER INC. | 3 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| ABBVIE INC. | 3 | $58 |
| Lilly USA, LLC | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Xeris Pharmaceuticals, Inc. | 2 | $33 |
| Astellas Pharma US Inc | 1 | $24 |
Products named: BREZTRI, Ozempic, Korlym, NURTEC ODT, FARXIGA, Kerendia, QULIPTA, JARDIANCE.
Industry payments across SC — which companies pay providers there.
